All of the following statements about clonidine are true EXCEPT:
**Question:** All of the following statements about clonidine are true EXCEPT:
A. Clonidine is a sympatholytic agent that reduces blood pressure and heart rate by blocking alpha-2 receptors.
B. Clonidine acts as an agonist at alpha-1 receptors, leading to increased heart rate and blood pressure.
C. Clonidine has sedative and anxiolytic effects, making it useful in the management of insomnia, anxiety, and attention deficit hyperactivity disorder (ADHD).
D. Clonidine is contraindicated in patients with severe renal impairment due to its potential to cause hypotension.
**Correct Answer:** B. Clonidine acts as an agonist at alpha-1 receptors, leading to increased heart rate and blood pressure.
**Core Concept:** Clonidine is an alpha-2 adrenergic receptor agonist, which means it binds to alpha-2 receptors and stimulates them, leading to a reduction in sympathetic activity.
**Why the Correct Answer is Right:** Clonidine is a sympatholytic agent, meaning it reduces sympathetic activity, which is opposite to what an alpha-1 receptor agonist would do. By binding to alpha-2 receptors, clonidine lowers blood pressure and heart rate, making option B incorrect.
**Why Each Wrong Option is Incorrect:**
A. Clonidine's primary action is as a sympatholytic agent, but this relates to its binding to alpha-2 receptors, not its effect on heart rate and blood pressure. So, this statement is correct.
C. Clonidine does have sedative and anxiolytic effects but its primary action is as a sympatholytic agent. Therefore, this statement is also correct.
D. While clonidine can cause hypotension in patients with severe renal impairment, the question does not mention renal impairment. Thus, this statement is incorrect.
**Clinical Pearl:** While clonidine is a useful medication in certain clinical scenarios such as hypertension and as an adjuvant for opioid-induced sedation, its primary action is as a sympatholytic agent. This understanding is crucial when prescribing clonidine and monitoring its effects in clinical practice.